Product overview
Vaccine type
Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3
Commercial Name
Poliomyelitis Vaccine (live, oral attenuated, human Diploid Cell), type 1 and 3
Manofacturer
Beijing Institute of Biological Products Co., Ltd.
Responsible NRA
National Medical Products Administration
Country
People's Republic of China
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
20
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
-20°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton containing 3 vials (60 doses)[Dimensions: 5.4 x 5.3 x 2.2 cm]
Tertiary Packaging
Box of 20 wrapped cartons containing 10 boxes of 3 vials each (600 vials/12000 doses)[Dimensions: 46 x 29.5 x 14 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
1.05 cm3/dose (in secondary packaging)
Attachments